Table 7. Summary of Various Reports of Disease-specific iPSC Generation.

This table is a summary of the various diseases that have had iPSCs generated from patient-specific cells. This table is not an exhaustive list and is meant to be representative.

Reference	Species	Disease
Liver Disease-specific Applications
(Hansel et al., 2013)	Human	CN-1
(Rashid et al., 2010)	Human	A1AT, FH, GSD, CN-1, tyrosinemia
(Ghodsizadeh et al., 2010)	Human	Tyrosinemia, GSD, progressive familial hereditary cholestasis, CN-1
(Yusa et al., 2011)	Human	A1AT
(Zhang et al., 2011)	Human	Wilson’s disease
Other Disease Applications
(Park et al., 2008a)	Human	adenosine deaminase deficiency-related severe combined immunodeficiency, Shwachman-Bodian-Diamond syndrome, Gaucher disease type III, muscular dystrophy, Parkinson disease, Huntington disease, juvenile-onset type 1 diabetes mellitus, down syndrome/trisomy 21, carrier state of Lesch-Nyhan syndrome
(Kazuki et al., 2010)	Mouse and Human	muscular dystrophy
(Soldner et al., 2009)	Human	Parkinson’s disease (transgene-free)
(Ebert et al., 2009)	Human	spinal muscular atrophy
(Lee et al., 2009)	Human	familial dysautonomia
(Meng et al., 2010)	Mouse	lysosomal storage disorders
(Pasca et al., 2011)	Human	Timothy syndrome
(Raya et al., 2009)	Human	Fanconi anemia
(Sebastiano et al., 2011)	Human	sickle cell anemia
(Dimos et al., 2008)	Human	Amyotrophic lateral sclerosis
(Sanchez-Danes et al., 2012)	Human	Genetic and sporadic Parkinson’s disease
(Lee et al., 2014)	Human	Rheumatoid arthritis and osteoarthritis